ASE Technology Holding Co., Ltd. (ASX): what the price requires

At today's price, ASE Technology Holding Co., Ltd. (ASX) is priced for today's economics sustained for ~21.5 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/ASX

Headline

FieldValue
TickerASX
CompanyASE Technology Holding Co., Ltd.
Current price$40.64/sh
CompositionPackaging 48% / Testing 11% / EMS 40% / Others 1%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin today8.0%
Must persist for21.5y
Multiple paid113x operating income

Solve inputs: computed at a 11.4% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.9 years.

Reconcile: at the x-ray's 9.3% required return this reads ~15.9 years; the models below use their own rates.

How unusual the bet is: elevated

ReferenceValue
vs own history+0.24σ
sustained it ~10 years at this level15%
implied end-window share3%

Valuation X-Ray

Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset11.35x5expensive
Earnings12.50x2expensive
Relative2.29x3expensive
Growth1.94x2expensive

Families that call it expensive: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.9%); the inversion above states its own rate.

Per-Model Detail (n=12)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$15.142.68xyesReference only (OCF-based, capex excluded): OCF $4.5B
DCF Exit MultipleGrowth$0.00—noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$17.782.29xyesP/E 48.4x (blended: static sector reference 22x + trailing (TTM) 134x), scenarios: 40.5x / 48.4x / 56.3x (bear / base = reference held flat / bull), EV/EBITDA 25.62x
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$3.2712.43xyesBV/sh $2.71, ROE (TTM) 11.2%, ke 9.3%
Two-Stage Excess ReturnAsset$3.5811.35xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$33.811.20xyesRev $20.6B, growth 1% (input: historical growth; tapered), Terminal P/S: 6.7x / 8.0x / 9.3x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/ERelative——no—
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$3.3712.06xyesNormalized EBIT (5y avg op income, one-time charges added back) $1.83B × (1−20%) / WACC 8.9% → EPV (no growth)
Residual IncomeAsset$3.6411.16xyesBV $2.71 + 5yr PV of (ROE (TTM) 11.2% − Kₑ 9.3%) × BV; BV grows 7.3%/yr
Graham NumberAsset$4.209.68xyes√(22.5 × EPS $0.29 × BVPS $2.71) — Graham's conservative floor
EV/EBITDA RelativeRelative$12.643.22xyesEBITDA $3.79B × sector EV/EBITDA 16.0x
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$0.24169.33xyesEPS $0.29 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAsset$2.2817.82xyesBV $2.71 × (ROIC 7.5% / WACC 8.9%)
P/Sales SectorRelative$23.701.71xyesRevenue $20.57B × sector P/S 5.0x
PEG Fair ValueRelative——no—
Earnings YieldEarnings$3.1412.94xyesEPS $0.29 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net debt$4.6b
Net debt / NOPAT (after-tax)3.48x
Net debt / operating income (pre-tax)2.79x
Interest coverage6.9x
Share count CAGR (dilution)0.2%
Burning cashno

Bullet Takeaways

Bull Case

The clearest way into ASE is the direction its margins are moving. In the first quarter of 2026 gross margin expanded to 20.1% from 16.8% a year earlier, and operating margin climbed to 10.1% from 6.5%, while local-currency earnings per share rose 85% year over year. That is not a slow grind; it is a business inflecting. The cause is mix. ASE's advanced-packaging work, the high-end assembly that AI accelerators require, is growing far faster than its commodity packaging, and high-end work carries richer margins. The company describes itself in its filings as offering "a total semiconductor manufacturing solution that includes access to foundry services in addition to our packaging, testing, and direct shipment services", and that breadth is exactly what positions it to capture the most demanding parts of the AI supply chain.

The strategic logic is that ASE sits one step downstream of the foundries and benefits when they run hot. As leading-edge logic gets harder to shrink, more of the performance gain comes from how chips are packaged together, and the foundries increasingly outsource that high-end packaging. ASE has guided its LEAP advanced-packaging revenue above $3.5 billion for 2026, a roughly 10% upward revision, after that line grew 167% to $1.6 billion. The company says in its 20-F that operating "at the levels of module, board, and system assembly and testing" helps it "better anticipate industry trends and take advantage of potential growth opportunities", which is the structural reason a packaging house can ride an AI compute wave rather than just a smartphone refresh.

The scale is the moat. ASE is the largest pure-play in its niche, which matters because advanced packaging is capital-intensive and the customers want a partner who can build capacity ahead of demand. A larger base spreads that capacity investment across more volume and gives the company first call on the highest-value programs. The balance sheet supports the build: interest coverage near 8.8 times on trailing operating income means the debt, while real, is comfortably serviced out of current earnings, and the company continues to return cash to holders, having declared a dividend with an ex-date in early July 2026. A company growing high-margin revenue this fast while still paying a dividend is signaling confidence in the durability of the ramp.

Bear Case

The bull case rests on one assumption above all others: that today's advanced-packaging surge is durable margin rather than a cycle peak. That is the fragile beam holding up the price. The semiconductor business has always been cyclical, and ASE's profitability swings with it. The company's own trailing operating margin of about 8.6% is well below the 10.1% it just printed, and an outsourced assembly-and-test house has limited control over its own volumes; when its customers slow, its expensive capacity sits idle and margins fall harder than revenue. The 20-F is direct that "Any deterioration of conditions in the markets for the end-use applications would" hurt the business, naming communications, computing, and consumer electronics as the end markets it depends on. AI demand is real, but it is one part of a cyclical whole.

Customer concentration sharpens the point. The filing states that although ASE has "a large customer base, we have derived, and expect to continue to derive, a large portion of our revenues from a small group of customers during any particular period." The very AI tailwind that is lifting margins comes from a handful of chip designers and foundries, so the strength is also the dependency. If a major customer dual-sources its high-end packaging, pushes pricing, or simply sees its own demand soften, ASE absorbs the blow with little diversification cushion. A packaging house is a price-taker at the bottom of the value chain; it captures a slice of the AI economics, not the bulk of them.

The price has run ahead of all of this. Measured against the four families of valuation method, no family reaches today's level. The asset-value methods, working off a book value near $2.71 a share, land roughly an order of magnitude below the price. The earnings-power methods, which capitalize current normalized profit, sit similarly far below. Even the relative and forward-growth methods, which credit the recovery, do not reach the price. Inverted, today's level prices the company at well over 100 times trailing operating income, which only resolves if operating growth holds at an aggressive pace for roughly two decades, a persistence that historically only a small minority of fast-growers have sustained even ten years. Layer on the financing structure, about $7.5 billion of gross debt and meaningful exposure to the New Taiwan dollar that the company hedges only "certain foreign currency risks" against, and the bear case is straightforward: the market is paying a peak-cycle multiple for a cyclical business, and the margin for error if the AI packaging ramp slows or the broader cycle rolls over is thin.

Valuation

The price is making a cyclical bet dressed as a secular one. At $40.58 (June 27, 2026), today's level prices ASE at well over 100 times its trailing company-wide operating income. Read that multiple plainly: it only makes sense if the company sustains aggressive operating-profit growth for something close to two decades. Of the companies that have grown at that pace, history says only a small fraction, on the order of 15%, kept it up even ten years. The reason the multiple looks so stretched is that trailing earnings are still climbing out of a cyclical trough, so the denominator is depressed; the forward picture, with advanced-packaging margins expanding, is better than the trailing ratio suggests. But even crediting the recovery, the price sits above what the standard methods support.

The disagreement among the methods is the whole story. The asset-value lens, anchored on book value near $2.71 a share plus the present value of returns above the cost of equity, lands far below the price because trailing returns only modestly exceed the cost of capital. The earnings-power lens, capitalizing normalized operating profit with no growth, lands similarly low. The peer-multiple lens, blending a sector price-to-earnings near 22 times against the company's elevated trailing multiple, reaches higher but still short. Only by extending the revenue base forward at a generous rate do any of the growth methods approach the price, and even they do not clear it. When no family of method reaches the price, the level is a bet beyond what any standard frame supports. That does not make it wrong; it makes it a wager on the AI packaging cycle running longer and richer than the methods will underwrite. It is worth noting that the published analyst average price target sits modestly below today's price even as the consensus rating is bullish, a tension that says the street likes the business but is wary of the entry multiple.

Solvency is comfortable enough that it does not threaten the equity in the near term, but it is not trivial. ASE carries roughly $7.5 billion of gross debt against $2.9 billion of liquid assets, with net debt around 0.7 times trailing operating income and interest coverage near 8.8 times. Share count is essentially flat, growing only about 0.2% a year, so the per-share case is not being eroded by dilution. The real downside variable is not the balance sheet; it is the cycle. The debt is serviceable at peak-cycle earnings; the question the price refuses to ask is what coverage and margins look like at the next trough.

Catalysts

The advanced-packaging ramp is the live catalyst. ASE reported first-quarter 2026 net revenue of NT$173.66 billion, up 17.2% year over year, with gross margin expanding to 20.1% from 16.8% and operating margin to 10.1% from 6.5%. The standout was the LEAP advanced-packaging line, which the company guided above $3.5 billion for 2026 after raising the estimate roughly 10%, citing AI-accelerator demand for the high-end packaging that foundries increasingly outsource. Each quarter through 2026 will test whether that mix shift continues to lift the blended margin or whether the broader cycle caps it.

Two nearer-term items frame the stock. The company declared a cash dividend with an ex-date of July 6, 2026, a reminder that it returns capital even while investing in capacity. And analyst sentiment is bullish on the business while cautious on the price: the consensus rating skews to the buy side, yet the average published price target sits close to or modestly below the current level, reflecting a market that credits the AI packaging story but questions paying a peak multiple for it. The next earnings report is the event that matters; it will show whether advanced-packaging revenue is tracking toward the raised guidance and whether margin expansion is holding.

Peer Cohorts (Per Segment, With Filing Citations)

Packaging (reported)

Testing (reported)

EMS (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 FY2026 results, May 2026 · Q1 FY2026 earnings call, May 2026 · company dividend announcement, June 2026 · analyst consensus, Simply Wall St, 2026 · analyst consensus, Simply Wall St / stockanalysis.com, 2026

View the full interactive ASX report on boothcheck